© Mirko Vitali – stock.adobe.comPharma companies increasingly use structured open-innovation platforms to access breakthrough science faster. Bayer Co.Lab exemplifies this: a global network of life science incubators giving start-ups labs, infrastructure, and pharma proximity to speed the path to clinic. CHEManager‘s Christene Smith spoke with Ruth Shah, Head of Bayer Co.Lab Berlin, about how the model works, its edge in a competitive incubator landscape, and how it delivers value for start-ups and pharma alike.
CHEManager: What needs to change in how large companies engage with early-stage innovators to make collaborations faster, more effective and genuinely founder-centric?
Ruth Shah: The first shift has to be one of mindset before mechanism. For open innovation to truly work, large companies need to approach early-stage innovators not as acquisition targets or option pools, but as partners who are building something of real, independent value. That means removing the friction that founders feel the moment they engage with a corporate.
Continue with login
No account yet?
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
Bayer AG
51368 Leverkusen
Germany
Innovation Pitch
Discover Tomorrow’s Innovators
The Start-up Platform for Chemistry & Life Sciences
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
Article
Reshaping Specialty Chemicals Manufacturing
The State of the US Specialty Chemicals Industry
SOCMA’s Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.
Top-Feature
Aseptic processing by design: The flexible and efficient use of RABS and Isolators
Predictive Simulation in Pharma Production
Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry
Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization
CHEManager International c/o Wiley-VCH GmbH
Upcoming Virtual Events
most read
Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF Sells Majority Stake in Coatings Business
BASF sells a majority stake in its coatings business to the investor Carlyle.
- DE
- EN
